Effects of Body-Mass-Scaled Protein and Leucine Supplementation on Body Composition and Cardiometabolic Blood Markers During Weight Loss in Older Men—A Randomized Controlled Trial
Nutrients · 2026
DOI: 10.3390/nu18193255 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Benedict Wei Jun Pang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Physical Education and Sports Science, National Institute of Education, Nanyang Technological University, Singapore 637616, Singapore. Hauptthemen laut MEDLINE: Body Composition, Dietary Proteins, Dietary Supplements, Leucine. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education.
Abstract (Originalsprache)
Background
Overweight and obesity are burgeoning health epidemics. Diets including alternate-day fasting (ADF) promote weight loss but risk significant muscle loss, posing health implications to seniors at risk of sarcopenia. Leucine, the key muscle protein synthesis (MPS) driver, effectively stimulates MPS with lower calorie intake than protein. However, the effects of body-mass-scaled protein and leucine intakes are unclear.
Objectives
To evaluate body-mass-scaled leucine or protein supplementation on body composition, sarcopenic, and cardiometabolic markers in older men during ADF.
Methods
Sixty-one older men (BMI ≥ 23.0 kg/m2) underwent 28 days of ADF, randomized across three calorie-matched supplement groups: Control (C: 0.0 g/kg protein, 0.0 g/kg leucine), Leucine (L: 0.0 g/kg protein, 0.08 g/kg leucine), or Protein (P: 0.4 g/kg protein, 0.04 g/kg leucine), consuming three doses on feeding days and one on fasting days. Dual-energy X-ray absorptiometry, sarcopenic metrics, and blood markers (blood pressure, lipid panels, diabetic profiles) were measured.
Results
There were no significant interactions (p > 0.05) in body composition, sarcopenic or health outcomes, except for diastolic blood pressure (p = 0.016) and HDL cholesterol (p = 0.013). There were significant main effects of time (p ≤ 0.05) with reductions in all body composition measures (excluding bone mineral density, p = 0.274), systolic blood pressure and lipid profiles (total and LDL cholesterol, total/HDL cholesterol ratio, triglycerides), and improvements in all muscle strength and functional sarcopenic outcomes.
Conclusions
Dietary interventions alone that increase leucine and/or protein intake did not result in additional measurable improvements during this four-week intervention on body composition, sarcopenic, and cardiometabolic outcomes during weight loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Physical Education and Sports Science, National Institute of Education, Nanyang Technological University, Singapore 637616, Singapore.
- Science of Learning in Education Centre, National Institute of Education, Nanyang Technological University, Singapore 637616, Singapore.
- Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-2425, USA.
ORCID-Profile: Benedict Wei Jun Pang, Yifan Yang, Bobby Kyungbeom Cheon
Förderung
- Ministry of Education
Zitieren
APA
Pang, B. W. J., Yang, Y., & Cheon, B. K. (2026). Effects of Body-Mass-Scaled Protein and Leucine Supplementation on Body Composition and Cardiometabolic Blood Markers During Weight Loss in Older Men—A Randomized Controlled Trial. Nutrients. https://doi.org/10.3390/nu18193255
Vancouver
Pang BWJ, Yang Y, Cheon BK. Effects of Body-Mass-Scaled Protein and Leucine Supplementation on Body Composition and Cardiometabolic Blood Markers During Weight Loss in Older Men—A Randomized Controlled Trial. Nutrients. 2026. doi:10.3390/nu18193255
BibTeX
@article{Pang2026,
author = {Pang, Benedict Wei Jun and Yang, Yifan and Cheon, Bobby Kyungbeom},
title = {Effects of Body-Mass-Scaled Protein and Leucine Supplementation on Body Composition and Cardiometabolic Blood Markers During Weight Loss in Older Men—A Randomized Controlled Trial},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18193255}
}
EUVIMED